Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: A randomised, cross-over, multicentre study

npj Primary Care Respiratory Medicine

Volumn 25, Issue , 2015, Pages

  Pascual, Sergi ^a   Feimer, Jan ^b   De Soyza, Anthony ^c,d   Sauleda Roig, Jaume ^e,f,g   Haughney, John ^h   Padullés, Laura ⁱ   Seoane, Beatriz ^i,j   Rekeda, Ludmyla ^k   Ribera, Anna ^i,j   Chrystyn, Henry ^l  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b Pneumologie Odeonsplatz   (Germany)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d FREEMAN HOSPITAL   (United Kingdom)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f Institut D'Investigació Sanitaria de Palma IdISPa   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h UNIVERSITY OF ABERDEEN   (United Kingdom)

ⁱ Medical Affairs ^*  (Spain)

^j ASTRAZENECA   (United Kingdom)

^k FOREST RESEARCH INSTITUTE   (United States)

^l UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; PLACEBO; RESPIRATORY TRACT AGENT;

AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG SAFETY; DRY POWDER INHALER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PATIENT PREFERENCE; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; CLINICAL TRIAL; DEVICE FAILURE; EQUIPMENT DESIGN; MIDDLE AGED; NEBULIZER; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA;

AGED; CROSS-OVER STUDIES; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PATIENT SATISFACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM AGENTS;

EID: 84933535700     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/npjpcrm.2015.18     Document Type: Article

References (24)

1. Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler. Int J Chron Obstruct Pulmon Dis 2009; 4: 381-390.
2. Newman SP. Principles of metered-dose inhaler design. Respir Care 2005; 50: 1177-1190.
3. van der Palen J, Ginko T, Kroker A, van der Valk P, Goosens M, Padulles L et al. Preference, satisfaction and errors with two dry powder inhalers in patients with COPD. Expert Opin Drug Deliv 2013; 10: 1023-1031.
4. Lavorini F, Fontana GA. Inhaler technique and patient's preference for dry powder inhaler devices. Expert Opin Drug Deliv 2014; 11: 1-3.
5. Yawn BP, Colice GL, Hodder R. Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. Int J Chron Obstruct Pulmon Dis 2012; 7: 495-502.
6. Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011; 37: 1308-1331.
7. Barrons R, Pegram A, Borries A. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease. Am J Health Syst Pharm 2011; 68: 1221-1232.
8. Chrystyn H, Small M, Milligan G, Higgins V, Garcia Gil E, Estruch J. Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med 2014; 108: 358-365.
9. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008; 102: 593-604.
10. Souza ML, Meneghini AC, Ferraz E, Vianna EO, Borges MC. Knowledge of and technique for using inhalation devices among asthma patients and COPD patients. J Bras Pneumol 2009; 35: 824-831.
11. Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011; 105: 930-938.
12. Broeders ME, Vincken W, Corbetta L. The ADMIT series-Issues in Inhalation Therapy. 7. Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique. Prim Care Respir J 2011; 20: 338-343.
13. Lareau SC, Yawn BP. Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis 2010; 5: 401-406.
14. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2010). http://www.goldcopd.com/guidelines-global-strategy-for-diagnosismanagement. html. Accessed 12 November 2014.
15. European Medicines Agency. Eklira Genuair (aclidinium bromide) (2012). http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002211/human-med-001571.jsp&mid=WC0b01ac058001d124. Accessed 2 June 2014.
16. Food and Drug Administration. Tudorza Pressair (aclidinium bromide) (2012). http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction= Search.DrugDetails. Accessed 2 June 2014.
17. European Medicines Agency. Duaklir Genuair (aclidinium bromide) (2014). http:/www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003745/human-med-001811.jsp&mid=WC0b01ac058001d124. Accessed 10 December 2014.
18. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2010). http://www.goldcopd.org/Guidelines/guideline-2010-gold-report. html. Accessed 20 October 2014.
19. Kozma CM, Slaton TL, Monz BU, Hodder R, Reese PR. Development and validation of a patient satisfaction and preference questionnaire for inhalation devices. Treat Respir Med 2005; 4: 41-52.
20. Hodder R, Reese PR, Slaton T. Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler. Int J Chron Obstruct Pulmon Dis 2009; 4: 225-232.
21. Ferguson GT, Ghafouri M, Dai L, Dunn LJ. COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study. Int J Chron Obstruct Pulmon Dis 2013; 8: 139-150.
22. Svedsater H, Dale P, Garrill K, Walker R, Woepse MW. Qualitative assessment of attributes and ease of use of the ELLIPTA dry powder inhaler for delivery of maintenance therapy for asthma and COPD. BMC Pulm Med 2013; 13: 72.
23. Small M, Anderson P, Vickers A, Kay S, Fermer S. Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomes. Adv Ther 2011; 28: 202-212.
24. Bryant L, Bang C, Chew C, Baik SH, Wiseman D. Adequacy of inhaler technique used by people with asthma or chronic obstructive pulmonary disease. J Prim Health Care 2013; 5: 191-198.